Live Breaking News & Updates on Nikhil Lalwani

Stay updated with breaking news from Nikhil lalwani. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

ANI releases Kionex Suspension

Kionex Suspension is a commercially available therapeutic equivalent to SPS Suspension for Oral or Rectal use. ....

Nikhil Lalwani , Drug Administration , Ani Pharmaceuticals , Sodium Polystyrene Sulfonate Suspension , Kionex Suspension ,

Kionex Suspension Now Available for Hyperkalemia Treatment

Kionex Suspension Now Available for Hyperkalemia Treatment
renalandurologynews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from renalandurologynews.com Daily Mail and Mail on Sunday newspapers.

Nikhil Lalwani , Drug Administration , Ani Pharmaceuticals , Rectal Use , Kionex Suspension ,

Quest Partners LLC Acquires Shares of 2,725 ANI Pharmaceuticals, Inc. (NASDAQ:ANIP)

Quest Partners LLC acquired a new position in ANI Pharmaceuticals, Inc. (NASDAQ:ANIP – Free Report) during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor acquired 2,725 shares of the specialty pharmaceutical company’s stock, valued at approximately $150,000. Other institutional investors and hedge […] ....

United States , Muthusamy Shanmugam , Nikhil Lalwani , Pharmaceuticals Profile , China Universal Asset Management Co , Quest Partners , Pacer Advisors Inc , Securities Exchange Commission , Pharmaceuticals Stock Performance , Cm Bidwell Associates Ltd , Pharmaceuticals Daily , Pharmaceuticals Inc , Allspring Global Investments Holdings , Free Report , Universal Asset Management , Global Investments Holdings , One Financial , Exchange Commission , Get Free Report , Visit Holdingschannel ,

Kionex Suspension Now Available for Hyperkalemia Treatment

Kionex (sodium polystyrene sulfonate suspension USP) Suspension for Oral or Rectal Use is now available for the treatment of hyperkalemia. ....

Nikhil Lalwani , Drug Administration , Ani Pharmaceuticals , Rectal Use , Kionex Suspension ,

Insider Selling: President & CEO Nikhil Lalwani Sells Shares of ANI Pharmaceuticals Inc (ANIP)

On May 14, 2024, Nikhil Lalwani, President & CEO of ANI Pharmaceuticals Inc (NASDAQ:ANIP), executed a sale of 16,669 shares of the company. ....

Pharmaceuticals Inc , Pharmaceutical Company , Nikhil Lalwani ,